MARTINSRIED, Germany, Sept. 26, 2007 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment) announced today that the U.S. Patent & Trademark Office has granted a fifth U.S. patent stemming from MorphoSys’s base HuCAL (Human Combinatorial Antibody Library) patent family, providing extended protection to MorphoSys’s core technology. The new patent (US 7,264,963) captures HuCAL’s modular design at the DNA level, providing solid product claim protection in the U.S.
